Effect of topical application of a stable prostacyclin analogue, SM-10902 on wound healing in diabetic mice

European Journal of Pharmacology

Volumn 302, Issue 1-3, 1996, Pages 53-60

  Yamamoto, Takaaki ^a   Horikawa, Naotsugu ^a   Komuro, Yoshihiro ^a   Hara, Youichi ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Angiogenesis; Blood flow, skin; Diabetic mouse (db db mouse), genetically; Prostacyclin analog; SM 10902 ointment; Wound healing

Indexed keywords

PIMILPROST; PROSTACYCLIN DERIVATIVE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EPIDERMIS; FEMALE; HISTOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SKIN BLOOD FLOW; SKIN ULCER; TOPICAL DRUG ADMINISTRATION; VASODILATATION; WOUND HEALING;

EID: 0030012839     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00019-2     Document Type: Article

References (38)

1. 1 on laurate-induced peripheral vascular occlusive sequelae in rabbits; optimized topical formulation with β-cyclodextrin derivative and penetration enhancer HPE-101, J. Pharm. Pharmacol. 44, 1033.
2. Barbara, R.R. and R.A.F. Clark, 1985, Cutaneous tissue repair: practical implications of current knowledge. II, J. Am. Acad. Dermatol. 13, 919.
3. Belch, J.J.F., A. Mckay, B. Mcardle, P. Leiberman, J.G. Pollock, G.D.O. Lowe, C.D. Forbes and C.R.M. Prentice, 1983a, Epoprostenol (prostacyclin) and severe arterial disease, Lancet i, 315.
4. Belch, J.J.F., P. Newman, J.K. Drury, F. Mckenzie, H. Capell, P. Leiberman, C.D. Forbes and C.R.M. Prentice, 1983b, Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome, Lancet i, 313.
5. Benezra, D., 1978, Neovasculogenic ability of prostaglandins, growth factors and synthetic chemoattractants, Am. J. Ophthalmol. 86, 455.
6. Bohlen, H.G. and B.A. Niggl, 1979, Adult microvascular disturbances as a result of juvenile-onset diabetes in db/db mice, Blood Vessels 16, 269.
7. Bunting, S., R. Gryglewski, S. Moncada and J.R. Vane, 1976, Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation, Prostaglandins 12, 897.
8. 1 in severe peripheral vascular disease. Lancet ii, 155.
9. Clark, R.A.F., 1985, Cutaneous tissue repair: basic biologic considerations. I, J. Am. Acad. Dermatol. 13, 701.
10. Coleman, D.L., 1982, Diabetes-obesity syndromes in mice, Diabetes 31 (Suppl. 1) 1.
11. 1 on platelet behavior in vitro and in vivo, Br. Med. J. 2, 468.
12. Fischer, B.H., 1969, Topical hyperbaric oxygen treatment of pressure sores and skin ulcers, Lancet ii, 405.
13. 2 and angiogenesis, Pros. Sec. Exp. Biol. Med. 172, 214.
14. Greenhalgh, D.G., K.H. Sprugel, M.J. Marrsy, and R. Ross, 1990, PDGF and FGF stimulate wound healing in the genetically diabetic mouse, Am. J. Pathol. 136, 1235.
15. Grossman, R.M. J. Krueger, D. Yourish, A. Granelli-Piperno, D.P. Murphy, L.T. May, T.S. Kupper, P.B. Sehgal and A.B. Gottlieb, 1989, Interleukin-6 is expressed in high levels in psoriasis skin and stimulates proliferation of cultured human keratinocytes, Proc. Natl. Acad. Sci. USA 86, 6367.
16. Hara, Y., T. Yamamoto, and N. Horikawa, 1995, Effects of the new stable prostacyclin analogue, SM-10902 ointment on the healing of experimental open wounds of aurisinterna in rabbits, Jpn. Pharmacol. Ther. 23, 1705.
17. Heng, M.C.Y., 1983, Local hyperbaric oxygen administration for leg ulcers, Br. J. Dermatol. 109, 232.
18. Ishida, H., H. Inoue, K. Kawabe, E. Isono and Y. Ogino, 1989, Effect of lysozyme chloride on growth of keratinocytes, J. Jpn. P.R.S. 9, 326.
19. 1: therapeutic potential for wound healing, Arch. Dermatol. Res. 287, 539.
20. 1 derivatives and their biological properties, Bioorg. Med. Chem. Lett. 3, 2821.
21. Kecskes, A. and E. Blitstein-Willinger, 1993, Pharmacological activity and local and systemic tolerance of topically applied iloprost, Arzneim.-Forsch./Drug Res. 43, 450.
22. Kitoh, Y., R. Oonishi, K. Itadami, K. Tsujimura, H. Tanaka, H. Okayachi, N. Kitabayashi, K. Namba and K. Takemura, 1994, Effects of ointment gauze containing lysozyme hydrochloride (M-1011G) on experimental rat models of incised wound, open wound and scald, Pharmacometrics 47, 67.
23. Koch-Weser, J. and J.D. Coffman, 1979, Vasodilator drugs in peripheral vascular disease, New Engl. J. Med. 300, 713
24. Komuro, Y., T. Nishimura, T. Yamamoto and Y. Hara, 1995, Usefulness of a new stable prostacyclin analogue, SM-10902 by transdermal application, Basic Clin. Rep. 29, 1435.
25. 1 in infants with critical congenital heart disease, Circulation 64, 893.
26. Mandel, M.A. and A.A.F. Mahmoud, 1978, Impairment of cell-mediated immunity in mutation diabetic mice (db/db), J. Immunol. 120, 1375.
27. Matuszewska, B., M. Keogan, D.M. Fisher, K.A. Soper, C.-M. Heo, A.C. Huber and J.V. Bondi, 1994, Acidic fibroblast growth factor: evaluation of topical formulations in a diabetic mouse wound healing model, Pharm. Res. 11, 65.
28. Moncada, S., R. Gryglewski, S. Bunting and J.R. Vane, 1976, An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation, Nature (London) 263, 663.
29. Ohtsu, A., K. Fujii and S. Kurozumi, 1988, Induction of angiogenic response by chemically stable prostacyclin analogs, Prostaglandins Leukotrienes Essential Fatty Acids 33, 35.
30. 1 analogues, SM-10906 and its methyl ester, SM-10902, in mastocytoma P-815 cells, Biol. Pharm. Bull. 17, 74.
31. Takaoka, T., H. Hatsuta, S. Ishiki and T. Konishi, 1972, Effects of lysozyme of the proliferation of fibroblasts in tissue culture, Jpn. J. Exp. Med. 42, 221.
32. Tsuboi, R. and D.B. Rifkin, 1990, Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice, J. Exp. Med. 172, 245.
33. 1 through hairless mouse skin: combined use of carboxymethylethyl-β-cyclodextrin and penetration enhancers, J. Pharm. Pharmacol. 44, 119.
34. Yamamoto, T., E. Satoh, N. Horikawa and Y. Hara, 1996, Effect of a new stable prostacyclin analogue, SM-10902 ointment on the healing of experimental decubitous ulcer of auricle in rabbits, Nishinihon J. Dermatol. (in press).
35. 1, Arzneim.-Forsch./Drug Res. 44, 483.
36. Yamamoto, T., T. Nishimura, N. Horikawa, Y. Komuro and Y. Hara, 1993, Effects of SM-10902, a new stable prostacyclin analogue on the excised wound healing in the genetically diabetic mouse, Jpn. Pharmacol. Ther. 21, 4549.
37. Zhang, Y., J.-X. Lin and J. Vilcek, 1988, Synthesis of interleukin 6 (interferon-β2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP, J. Biol. Chem. 263, 6177.
38. 1 and copper in angiogenesis, J. Natl. Can. Inst. 69, 475.